Publications of Yvonne Genzel

Genzel, Y.: ESACT Course on Cell Culture-based Viral Vaccines (7^th Edition): Overview on COVID-19 candidate vaccines. Introduction Exercise. ESACT Course 2022, Llafranc (Spain) (2022)

Genzel, Y.: ESACT Course on Cell Culture-based Viral Vaccines (7^th Edition): Exercise on vaccine design. ESACT Course 2022, Llafranc (Spain) (2022)

Göbel, S.; Pelz, L.; Behrendt, I.; Prömmel, M.; Altomonte, J.; Anderlei, T.; Bürgin, T.; Genzel, Y.; Reichl, U.: Scale-Down of an Ortbital Shaken Bioreactor: High Cell Density Cultivation in Perfusion Mode and Virus production. Single-Use Technologies V: Building the Future, Marseille, France (2022)

Gränicher, G.; Göbel, S.; Marichal-Gallardo, P.; Jordan, I.; Sandig, V.; Genzel, Y.; Reichl, U.: Integrated cell-culture based MVA virus production process with perfusion mode for vaccines or gene therapy. Value through intensified bioprocessing II, Oxford, United Kingdom (2022)

Gränicher, G.; Göbel, S.; Marichal-Gallardo, P.; Jordan, I.; Sandig, V.; Genzel, Y.; Reichl, U.: Integrated cell-culture based MVA virus production process with perfusion mode for vaccines or gene therapy. 27th ESACT Meeting, Lisbon (Portugal) (2022)

Hein, M.; Chawla, A.; Arora , P.; Cattaneo, M.; Winkler, M.; Pöhlmann, S.; Schughart, K.; Genzel, Y.; Kupke, S. Y.; Reichl, U.: Production of influenza A virus defective interfering particles in a high cell density perfusion cultivation with continuous virus harvesting. Vaccine Technology VIII, Sitges (Spain) (2022)

Hein, M.; Dogra, T.; Arora , P.; Rand , U.; Genzel, Y.; Cattaneo, M.; Winkler, M.; Cicin-Sain, L.; Bruder, D.; Schughart, K. et al.; Pöhlmann, S.; Kupke, S. Y.; Reichl, U.: Influenza A Virus-Derived Defective Interfering Particles for Antiviral Treatment. 27th ESACT Meeting, Lisbon (Portugal) (2022)

Pelz, L.; Rüdiger, D.; Dogra, T.; Alnaji, F.G.; Genzel, Y.; Brooke, C.B.; Kupke, S. Y.; Reichl, U.: Long-Term Propagation of Influenza A Virus and Its Defective Interfering Particles: Analyzing Dynamic Competition to Select Antiviral Candidates. Vaccine Technology VIII, Sitges (Spain) (2022)

Pelz, L.; Rüdiger, D.; Dogra, T.; Alnaji, F. G.; Genzel, Y.; Brooke, C. B.; Kupke, S. Y.; Reichl, U.: Semi-Continuous propagation of Influenza A virus and its defective interfering particles: Analyzing the dynamic competition to select antiviral candidates. 27th ESACT Meeting, Lisbon (Portugal) (2022)

Zinnecker, T. M.; Behrendt, I.; Lau , M.; Hinkelmann, A.; Thiele, K.; Badri, N.; Araujo, D.; Genzel, Y.; Reichl, U.: Automated single-cell cloning in chemically defined medium for new suspension MDCK cell lines and scale-down of influenza A virus production into ambr^®15 microbioreactors. Vaccine Technology VIII, Sitges (Spain) (2022)

Genzel, Y.: ESACT Course on Cell Culture-based Viral Vaccines (6^th Edition):Cells, Upstream Processing and Process Intensification. ESACT Course 2021, Virtual Meeting (2021)

Genzel, Y.: ESACT Course on Cell Culture-based Viral Vaccines (6^th Edition): Overview on COVID-19 candidate vaccines. ESACT Course 2021, Virtual Meeting (2021)

Genzel, Y.: ESACT Course on Cell Culture-based Viral Vaccines (6^th Edition): Exercise on COVID-19 antigen design options and vaccination platforms. ESACT Course 2021, Virtual Meeting (2021)

Genzel, Y.: ESACT Course on Cell Culture-based Viral Vaccines (6^th Edition): Exercise on COVID-19 vaccine manufacturing platforms and cost-effectiveness. ESACT Course 2021, Virtual Meeting (2021)

Genzel, Y.: ESACT Course on Cell Culture-based Viral Vaccines (6^th Edition): Exercise on COVID-19 vaccines immunology and protection. ESACT Course 2021, Virtual Meeting (2021)

Genzel, Y.: Process intensification for virus production: stirred or shaken perfusion leads to very high titres. World Vaccine Congress Washington, Virtual Meeting (2020)

Genzel, Y.: ESACT Course on Cell Culture-based Viral Vaccines (5^th Edition):Cells, Upstream Processing and Process Intensification. ESACT Course 2020, Virtual Meeting (2020)

Genzel, Y.: ESACT Course on Cell Culture-based Viral Vaccines (5^th Edition): Overview on COVID-19 candidate vaccines. ESACT Course 2020, Virtual Meeting (2020)

Genzel, Y.: ESACT Course on Cell Culture-based Viral Vaccines (5^th Edition): Exercise on COVID-19 antigen design options and vaccination platforms. ESACT Course 2020, Virtual Meeting (2020)

Genzel, Y.: ESACT Course on Cell Culture-based Viral Vaccines (5^th Edition): Exercise on COVID-19 vaccine manufacturing platforms and cost-effectiveness. ESACT Course 2020, Virtual Meeting (2020)